Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

Matthew Krebs, Robert Szczepaniak‐Sloane, Lynsey Priest, +10

Journal of Clinical Oncology

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

Jian-Mei Hou, Matthew Krebs, Lee Lancashire, +10

Journal of Clinical Oncology

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Matthew Krebs, Jianmei Hou, Robert Szczepaniak‐Sloane, +10

Journal of Thoracic Oncology

Tumor BiologyOncologyCancer DetectionMedicineCirculating Tumor Cells +8

Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer

Jianmei Hou, Matthew Krebs, Tim Ward, +7

American Journal Of Pathology

Cancer ResearchOncologyMedicineBiological MicroenvironmentsMetastasis Biology +7

Circulating tumour cells: their utility in cancer management and predicting outcomes

Matthew Krebs, Jian-Mei Hou, Tim Ward, +2

Therapeutic Advances in Medical Oncology

Ctc NumberCancer ManagementBiological MicroenvironmentsPathologyTumor Biology +20

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

Gordon C. Jayson, Jamal Zweit, Alan Jackson, +20

JNCI Journal of the National Cancer Institute

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Jianmei Hou, Alastair Greystoke, Lee Lancashire, +11

American Journal Of Pathology

Prognostic BiomarkersMedicineCirculating Tumor CellsPathologyBronchial Neoplasm +6

ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer

Richard Booton, Tim Ward, Linda Ashcroft, +3

Journal of Thoracic Oncology

MedicineCancer BiologyPlatinum-based Chemotherapy RegimensCancer TreatmentRadiation Oncology +5

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado‐Barrera, +125

Radiotherapy and Oncology

Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer

Emma Dean, Duncan I. Jodrell, Kate Connolly, +13

Journal of Clinical Oncology